동물 장 건강 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 제품별, 투여 방법별, 기능별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Animal Intestinal Health Market Growth & Trends:

The global animal intestinal health market size is expected to reach USD 7.72 billion by 2030, at a projected CAGR of 8.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Primary market growth drivers include rising R&D initiatives and the emergence of substitute products for animal intestinal health. Key industry participants are engaging in research activities to approach intestinal health complications in a more structured and scientific manner by creating knowledge bases and recommendations for both veterinarians & animal owners. This will boost the innovative spirit of the market and assist in the development of novel products that enhance the current gut health treatment regimes.

For instance, in April 2024, Nestle introduced the Petivity Microbiome Analysis Kit, which employs stool samples to provide customized information regarding the gut health of companion animals such as dogs and cats. This makes it possible for the experts to modify the nutrition and supplements according to every pet's microbiome. With more than a decade of research behind it, the kit makes assumptions about the health of the pet's digestive system. These developments offer proactive solutions for professionals seeking ways to enhance pet's well-being, presenting a holistic approach to pet care.

Furthermore, a worldwide study was conducted in 2021, which studied the gut microbiota in poultry worldwide. This Agrifutures Ag study acknowledged that the productivity of layer flocks relies on the gut microbiota and provided comprehensive data on the normal baseline composition of the gut microbiota in healthy layer poultry in cage, barn, and free-range systems.

Future research on gut health, such as an assessment of gut health therapies and techniques for expanding the duration of egg production and preserving egg quality during the lay, can be designed upon the findings of this project.

The industry leaders are encouraging research culture in this industry by investing in startups and other promising ongoing research studies to translate them into commercial animal well-being solutions. For example, in 2021, Cargill invested in a California, U.S.-based startup known as AnimalBiome. This company aims to develop solutions that can diagnose, restore, and maintain the gut health of companion animals like dogs, cats & horses. The company has thorough research backing of over 20 years in animal microbiome research. Such market developments portray a promising future for animal intestinal health.

Animal Intestinal Health Market Report Highlights:

• Based on animal type, the production animal segment held a dominant share of 74.7% in 2024. Increased consumption of meat and dairy products is a major factor driving the segment growth.
• Based on product, the nutrition segment dominated the market in 2024, with a market share of 83.6%, and is anticipated to grow at a CAGR of 8.14% over the forecast period. This segment is further segmented into products like probiotics, prebiotics, postbiotics, phytogenics, enzymes, and immunomodulators.
• Based on mode of delivery, the feed/water additives segment dominated the market in 2024, with a revenue share of over 61.5%. This can be attributed to the high palatability and animal compliance.
• Based on function, the preventive care segment dominated the animal intestinal health market in terms of share in 2024 and CAGR over the forecast period. This can be attributed to the fact that products like probiotics, prebiotics, and immunomodulators are widely used in various nutritional regimes for animals like cattle, poultry, swine, dogs, cats, and horses.
• Based on distribution channel, the animal farms segment dominated the market in terms of revenue share in 2024 owing to the high adoption of feed additives in these channels.
• The Asia Pacific region held the largest global revenue share of over 31.9% in 2024 and is anticipated to witness the fastest growth over the years 2024-2030. This region is home to two of the world's largest animal husbandry producers, India and China.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Animal Intestinal Health Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Shift towards increasing usage of gut health nutritional products
    • 3.2.1.2. Rising livestock population & production
    • 3.2.1.3. Rising gut health complications in animals
    • 3.2.1.4. Emergence of prebiotics & probiotics as an alternative to antibiotics
    • 3.2.1.5. R&D advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulations
    • 3.2.2.2. Reduction in animal feed volume
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Animal Intestinal Health Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2024

Chapter 4. Animal Intestinal Health Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Animal Intestinal Health Market: Animal type Movement Analysis
• 4.3. Animal Intestinal Health Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Production Animal
  • 4.4.1. Production Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Cattle
    • 4.4.2.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Swine
    • 4.4.3.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Poultry
    • 4.4.4.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Others (sheep, goats, aquaculture, etc.)
    • 4.4.5.1. Others (sheep, goats, aquaculture, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion Animal
  • 4.5.1. Companion Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Canine
    • 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Feline
    • 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Equine
    • 4.5.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others (turtles, fish, rabbit, etc.)
    • 4.5.5.1. Others (turtles, fish, rabbit, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Animal Intestinal Health Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Animal Intestinal Health Market: Product Movement Analysis
• 5.3. Animal Intestinal Health Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
• 5.4. Nutrition
  • 5.4.1. Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Probiotics
    • 5.4.2.1. Probiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Prebiotics
    • 5.4.3.1. Prebiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Postbiotics
    • 5.4.4.1. Postbiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5. Phytogenics
    • 5.4.5.1. Phytogenics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.6. Enzymes
    • 5.4.6.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.7. Immunomodulators
    • 5.4.7.1. Immunomodulators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Pharmaceutical
  • 5.5.1. Pharmaceutical Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Antibiotics
    • 5.5.2.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Others
    • 5.5.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Animal Intestinal Health Market: By Mode of Delivery Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Animal Intestinal Health Market: By Mode of Delivery Movement Analysis
• 6.3. Animal Intestinal Health Market Size & Trend Analysis, by mode of delivery, 2018 to 2030 (USD Million)
  • 6.3.1. Feed/Water Additives
    • 6.3.1.1. Feed/Water Additives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Supplements & Tablets
    • 6.3.2.1. Supplements & Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Other mode of delivery
    • 6.3.3.1. Other mode of delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Animal Intestinal Health Market: By Function Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Animal Intestinal Health Market: By Function Movement Analysis
• 7.3. Animal Intestinal Health Market Size & Trend Analysis, by function, 2018 to 2030 (USD Million)
  • 7.3.1. Preventive Care
    • 7.3.1.1. Preventive Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Disease Treatment
    • 7.3.2.1. Disease Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Animal Intestinal Health Market: By Distribution Channel Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Animal Intestinal Health Market: By Distribution Channel Movement Analysis
• 8.3. Animal Intestinal Health Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
  • 8.3.1. Veterinary Hospitals/Clinics
    • 8.3.1.1. Veterinary Hospitals/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. Animal Farms
    • 8.3.2.1. Animal Farms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. E-Commerce
    • 8.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Animal Specialty Stores
    • 8.3.4.1. Animal Specialty Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.5. Other Distribution Channel
    • 8.3.5.1. Other Distribution Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Animal Intestinal Health Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Animal Intestinal Health Market Share, By Region, 2024 & 2030, USD Million
• 9.3. Regional Outlook
• 9.4. North America
  • 9.4.1. North America Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. U.S. Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Canada Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Mexico Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. UK Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Germany Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. France Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Italy Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Spain Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Denmark Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Sweden Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Norway Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Japan Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. China Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. India Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Australia Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. South Korea Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Thailand Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Brazil Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Argentina Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8. Middle East & Africa
  • 9.8.1. Middle East & Africa Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. South Africa Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Saudi Arabia Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. UAE Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Kuwait Animal Intestinal Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. Cargill
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Evonik Industries
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Kemin Industries
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Alltech
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. dsm-firmenich (DSM)
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. Adisseo
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. Kerry Group Plc.
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Novozymes A/S
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Karyotica Biologicals Pvt. Ltd.
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. EW Nutrition
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
  • 10.3.11. AB Vista
    • 10.3.11.1. Participant's Overview
    • 10.3.11.2. Financial Performance
    • 10.3.11.3. Product Benchmarking
    • 10.3.11.4. Strategic Initiatives
  • 10.3.12. AdvaCarePharma
    • 10.3.12.1. Participant's Overview
    • 10.3.12.2. Financial Performance
    • 10.3.12.3. Product Benchmarking
    • 10.3.12.4. Strategic Initiatives
  • 10.3.13. ADM
    • 10.3.13.1. Participant's Overview
    • 10.3.13.2. Financial Performance
    • 10.3.13.3. Product Benchmarking
    • 10.3.13.4. Strategic Initiatives
  • 10.3.14. Zoetis
    • 10.3.14.1. Participant's Overview
    • 10.3.14.2. Financial Performance
    • 10.3.14.3. Product Benchmarking
    • 10.3.14.4. Strategic Initiatives
  • 10.3.15. Boehringer Ingelheim
    • 10.3.15.1. Participant's Overview
    • 10.3.15.2. Financial Performance
    • 10.3.15.3. Product Benchmarking
    • 10.3.15.4. Strategic Initiatives
  • 10.3.16. Dechra Pharmaceuticals
    • 10.3.16.1. Participant's Overview
    • 10.3.16.2. Financial Performance
    • 10.3.16.3. Product Benchmarking
    • 10.3.16.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Expansion
  • 10.4.4. Product launch
  • 10.4.5. Product Approval
  • 10.4.6. Others
• 10.5 List of Key Companies
  • 10.5.1 List of Manufacturers
  • 10.5.2 List of Distributors